Standex International Corporation (SXI) Guidance & Earnings Results

On 2026-07-31 Standex International Corporation raised guidance: "FY27: mid-to-high single digit sales growth; high single-digit to low double-digit organic growth; adjusted operating margin…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SXIStandex International CorporationFollow SXI — free

Specialty Industrial Machinery · Industrials

—

Price chart with a free account

Market cap: 2.9B
P/E TTM: —
Dividend yield: 0.6%
52-week: —
Next earnings: 29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
31 Jul 26	Raised	FY27: mid-to-high single digit sales growth; high single-digit to low double-digit organic growth; adjusted operating margin expansion · full year
5 May 26	Reaffirmed	FY2026 revenue growth ~$100M after divestiture; fast growth markets ~$270M. · full year
4 Feb 26	Reaffirmed	FY2026 sales growth >$110M over FY25; fast growth market sales >$270M · full year
31 Oct 25	Raised	FY26 sales outlook raised to >$110M over FY25 (from >$100M) · full year
5 Aug 25	Raised	FY26 revenue growth >$100M; fast growth market sales expected to grow ~45% to exceed $265M; 15+ new products contributing ~300bps growth; continued adjusted operating margin expansion · full year

Standex International Corporation — questions

What guidance did Standex International Corporation give?: On 2026-07-31: "FY27: mid-to-high single digit sales growth; high single-digit to low double-digit organic growth; adjusted operating margin expansion"
When does Standex International Corporation report earnings?: Standex International Corporation's next earnings report is expected on 2026-10-29.

Every figure on this page comes from Standex International Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.